AstraZeneca
The role leads the development and execution of bioanalytical strategies for cell and gene therapy programs, overseeing assay development, external partnerships, and data integration to support clinical decision‑making and regulatory submissions. The leader collaborates with clinicians, translational scientists, and CROs to deliver high‑quality, decision‑grade data that accelerates therapy development.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
Senior Scientist, Bioanalytical Sciences (Innate Immunity, Ligand Binding Assays & Flow Cytometry)
Flagship Pioneering, Inc.
Scientist I/II, Pharmacology and Translational Science
Artiva Biotherapeutics
Executive Director, Head of Bioanalytical Sciences
Dianthus Therapeutics
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Sr. Research Associate, CLIA Lab Immunology
AskBio
Principal Scientist, Bioanalytical Assays
Flagship Pioneering, Inc.